4
Changes in Ownership
Tango Therapeutics, Inc. Filed Acc 0000950170-24-070875
Director sold 5,000 shares at $7.21 ($36,039)
- Director acquired 6,250 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Calhoun Lesley Ann · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-05 | Grant or award : show line 1 in the form 10b5-1 | +6,250 | 11,250 | D | ||
| 2024-06-05 | Sale : show line 2 in the form 10b5-1 | +5,000 | $7.21 | $36,039 | 6,250 | D |
| Open-market sales · 5,000 sh · avg $7.21 · $36,039 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-05 | Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | +37,500 | 37,500 | D |
Loading xslF345X05/ownership.xml…